Presentation: Gene Therapy 2.0: Leveraging Transgene Cassette Engineering
Time: 11:05 am
day: Gene Therapy 2.0: Leveraging Transgene Cassette Engineering
Details:
- Learn how investing in the design of every vector component can enable vector potencies 10x or higher than first generation candidates with equal or better manufacturing yields
- Discover the importance of selecting scalable manufacturing platforms that can expand from early phase to later phase studies and beyond
- Tap into how using the ECO system resulted in viral vectors configured specifically for ex vivo gene delivery and expression from autologous hematopoietic cells and allogeneic gamma delta T cells, as well as for liver-expression directed vectors that are entering the clinic now
